Comparing the PLCO and ERSPC trials on efficacy of prostate cancer screening

Bookmark and Share
Published: 3 Oct 2013
Views: 5161
Prof Jack Cuzick - Wolfson Institute of Preventive Medicine, London, UK

Prof Jack Cuzick talks to ecancer at the 2013 European Cancer Congress in Amsterdam about the role of prostate cancer screening and why two trials, European Randomized Study of Screening for Prostate Cancer (ERSPC) and the PLCO trial, came to different conclusions about its benefits.